• Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Pharmaceutical Patent Decisions
    • Patent Information & Databases
    • IP & Health Links
  • Donate

I-MAK

Initiative For Medicines, Access & Knowledge
  • Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Pharmaceutical Patent Decisions
    • Patent Information & Databases
    • IP & Health Links
  • Donate

  • Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Pharmaceutical Patent Decisions
    • Patent Information & Databases
    • IP & Health Links
  • Donate
Search

 

Subscribe Via RSS

 

Or Email

Enter your email address:

Delivered by FeedBurner

 

Archive

Entries by Category

Click on a category below to view a list of all entries within that category.
  • Abacavir (1)
  • AIDS (3)
  • Competition (1)
  • Country Watch (1)
  • Divisional Patents (1)
  • Erlotinib (1)
  • HIV Drug Patent Update (1)
  • Maraviroc (2)
  • Neglected Diseases (1)
  • Nevirapine (1)
  • Patent Pools  (2)
  • Pre-95 Inventions (1)
  • Pre-grant Opposition (2)
  • Raltegravir (2)
  • Tenofovir (10)
  • Transparency (2)
  • Valganciclovir (2)

Entries by Month

Click on a month below to view a list of articles published during that month.
  • September 2009 (1)
  • July 2009 (4)
  • May 2009 (5)
  • December 2008 (2)
  • September 2008 (1)
  • August 2008 (1)
  • July 2008 (2)
  • June 2008 (3)
  • May 2008 (1)
  • April 2008 (2)
  • March 2008 (2)
  • February 2008 (1)
  • January 2008 (3)
  • December 2007 (4)
  • November 2007 (1)
  • October 2007 (2)
  • September 2007 (1)
Except for publications commissioned or published by third parties all content on this site is licensed under a Creative Commons Attribution 3.0 License